512 related articles for article (PubMed ID: 10027397)
1. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D
Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397
[TBL] [Abstract][Full Text] [Related]
2. [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma].
Breiteneder-Geleff S; Soleiman A; Horvat R; Amann G; Kowalski H; Kerjaschki D
Verh Dtsch Ges Pathol; 1999; 83():270-5. PubMed ID: 10714221
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
4. CD9 expression on lymphatic vessels in head and neck mucosa.
Erovic BM; Neuchrist C; Kandutsch S; Woegerbauer M; Pammer J
Mod Pathol; 2003 Oct; 16(10):1028-34. PubMed ID: 14559986
[TBL] [Abstract][Full Text] [Related]
5. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors.
Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA
Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
Kahn HJ; Bailey D; Marks A
Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
[TBL] [Abstract][Full Text] [Related]
8. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
Miettinen M; Wang ZF
Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.
Weninger W; Partanen TA; Breiteneder-Geleff S; Mayer C; Kowalski H; Mildner M; Pammer J; Stürzl M; Kerjaschki D; Alitalo K; Tschachler E
Lab Invest; 1999 Feb; 79(2):243-51. PubMed ID: 10068212
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.
Jussila L; Valtola R; Partanen TA; Salven P; Heikkilä P; Matikainen MT; Renkonen R; Kaipainen A; Detmar M; Tschachler E; Alitalo R; Alitalo K
Cancer Res; 1998 Apr; 58(8):1599-604. PubMed ID: 9563467
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin is a useful diagnostic marker for epithelioid hemangioendothelioma of the liver.
Fujii T; Zen Y; Sato Y; Sasaki M; Enomae M; Minato H; Masuda S; Uehara T; Katsuyama T; Nakanuma Y
Mod Pathol; 2008 Feb; 21(2):125-30. PubMed ID: 18084256
[TBL] [Abstract][Full Text] [Related]
12. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas.
Poblet E; Gonzalez-Palacios F; Jimenez FJ
Virchows Arch; 1996 Jul; 428(4-5):217-21. PubMed ID: 8764929
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development.
Pyakurel P; Pak F; Mwakigonja AR; Kaaya E; Heiden T; Biberfeld P
Int J Cancer; 2006 Sep; 119(6):1262-7. PubMed ID: 16615115
[TBL] [Abstract][Full Text] [Related]
15. Differential Prox-1 and CD 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumors.
Reis RM; Reis-Filho JS; Longatto Filho A; Tomarev S; Silva P; Lopes JM
Pathol Res Pract; 2005; 201(12):771-6. PubMed ID: 16308102
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach.
Evangelou E; Kyzas PA; Trikalinos TA
Mod Pathol; 2005 Nov; 18(11):1490-7. PubMed ID: 15990898
[TBL] [Abstract][Full Text] [Related]
17. Expression of FKBP12 in benign and malignant vascular endothelium: an immunohistochemical study on conventional sections and tissue microarrays.
Higgins JP; Montgomery K; Wang L; Domanay E; Warnke RA; Brooks JD; van de Rijn M
Am J Surg Pathol; 2003 Jan; 27(1):58-64. PubMed ID: 12502928
[TBL] [Abstract][Full Text] [Related]
18. Transient Expression of Lymphatic Markers in Retrobulbar Intraconal Orbital Vasculature During Fetal Development.
van den Bosch QCC; van Beek JGM; Kiliç E; Verdijk RM
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):22. PubMed ID: 32516408
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors.
Miettinen M; Rikala MS; Rys J; Lasota J; Wang ZF
Am J Surg Pathol; 2012 Apr; 36(4):629-39. PubMed ID: 22314185
[TBL] [Abstract][Full Text] [Related]
20. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.
Lymboussaki A; Partanen TA; Olofsson B; Thomas-Crusells J; Fletcher CD; de Waal RM; Kaipainen A; Alitalo K
Am J Pathol; 1998 Aug; 153(2):395-403. PubMed ID: 9708800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
